Table 2.
Relationship of IR surrogate indicators or sarcopenia status with stroke risk
| Characteristics | Crude model | Adjusted model | P for interactionc | ||
|---|---|---|---|---|---|
| HR(95%CI) | P | HR(95%CI) | P | ||
| IR surrogate indicators | |||||
| TyG (per SD) | 1.26 (1.16,1.36) | < 0.001 | 1.13 (1.03,1.23) | 0.006 | 0.221 |
| TyG-BMI (per SD) | 1.27 (1.18,1.37) | < 0.001 | 1.10 (1.01,1.20) | 0.035 | 0.384 |
| TyG-WC (per SD) | 1.35 (1.25,1.47) | < 0.001 | 1.12 (1.02,1.22) | 0.013 | 0.222 |
| TyG-WHtR (per SD) | 1.33 (1.23,1.45) | < 0.001 | 1.12 (1.02,1.23) | 0.015 | 0.240 |
| TG/HDL-C (per SD) | 1.12 (1.06,1.19) | < 0.001 | 1.06 (0.99,1.14) | 0.087 | 0.164 |
| METS-IR (per SD) | 1.27 (1.18,1.37) | < 0.001 | 1.11 (1.02,1.21) | 0.017 | 0.596 |
| Sarcopenia statusa | |||||
| Non-sarcopenia | 1.00(Reference) | 1.00(Reference) | |||
| Possible sarcopenia | 1.90 (1.58,2.28) | < 0.001 | 1.49(1.23,1.81) | < 0.001 | |
| Sarcopenia | 1.44 (1.08,1.91) | 0.013 | 1.30 (0.95,1.77) | 0.101 | |
| Sarcopenia statusb | |||||
| Non-sarcopenia | 1.00(Reference) | 1.00(Reference) | |||
| Possible sarcopenia and sarcopenia | 1.77 (1.49,2.11) | < 0.001 | 1.45 (1.20,1.75) | < 0.001 | |
Adjusted model: adjusted for Age, Sex, Systolic, Diastolic, Smoking, Drinking, Hypertension, Diabetes, Heart disease, Dyslipidemia, Hypertension medications, Diabetes medications and Dyslipidemia medications. IR surrogate indicators is analyzed as a continuous variable in the table
aSarcopenia status is classified into three categories
bSarcopenia status is classified into two categories
cInteraction between IR surrogate indicators and sarcopenia statusb